Cited by 124Dialysis and Renal Disease ManagementDementia and Cognitive Impairment ResearchChronic Kidney Disease and Diabetes

Neuropsychiatric Disorders in Chronic Kidney Disease

Open access
Simões e Silva, Ana Cristina, Miranda, Aline Silva, Rocha, Natalia Pessoa, Teixeira, Antônio Lúcio·2019·Frontiers in Pharmacology

Abstract

Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2019.00932

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neuropsychiatric conditions such as depression, anxiety, psychosis, and cognitive impairment are often prevalent in patients with chronic kidney disease, non-alcoholic fatty liver disease, and autoimmune disorders.

    “Neuropsychiatric conditions, such as depression, anxiety, psychosis, and cognitive impairment, are often prevalent in patients with chronic kidney disease (CKD), non-alcoholic fatty liver disease (NAFLD), and autoimmune disorders”

    From A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior (2022) · cites this paper as Simões e Silva et al., 2019

    The Introduction and “Brain-Renal Axis: An Evolving Concept” sections describe depression, anxiety, and cognitive impairment as common or prevalent in CKD. The paper does not establish that psychosis is prevalent in CKD, or address the claimed prevalence of these conditions in NAFLD or autoimmune disorders. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Simões e Silva, A. C., Miranda, A. S., Rocha, N. P., & Teixeira, A. L.
Affiliations
Universidade Federal de Minas Gerais (BR)
Venue
Frontiers in Pharmacology
Published
2019-08-16
Volume
10
Pages
932-932
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2964181807
Cited by
124
References
118
Citations by year
2026: 10 · 2025: 25 · 2024: 21 · 2023: 22 · 2022: 24 · 2021: 16 · 2020: 6
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (406041/2018-0, 301037/2016-7)
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
chronic kidney disease, neuropsychiatric disorders, depression, anxiety disorders, cognitive impairment, uremic toxins, cerebrovascular disease, vascular risk factors, pediatric chronic kidney disease, pathophysiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review